Condition
Wet Age-related Macular Degeneration clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Wet Age-related Macular Degeneration clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Czechia (1), China (1)). By phase: Phase 2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Wet Age-related Macular Degeneration clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Topical NT-101 in wet age-related macular degeneration | Phase 2 | Bonita Springs, Florida and 2 other locations | Recruiting | Sep 10, 2026 |
| Comparing 8-week and 12-week follow-up intervals for treating wet AMD with faricimab | Phase 4 | Prague | Recruiting | Mar 13, 2025 |
| Long-term follow-up of EXG102-031 treatment for wet age-related macular degeneration | — | Beijing | Recruiting | Mar 5, 2025 |
| Low-dose oral doxycycline targeting MMP-9 for persistent wet AMD | Phase 2 | Iowa City, Iowa | Recruiting | Aug 7, 2020 |
All recruiting trials (4)
-
Topical NT-101 in wet age-related macular degeneration
A topical eye drop (NT-101) is being tested to see if it can help people 50 and older with wet AMD when used twice daily for 12 weeks.
-
Comparing 8-week and 12-week follow-up intervals for treating wet AMD with faricimab
This study is testing whether patients with wet age-related macular degeneration can benefit more from follow-up treatments every 8 weeks or every 12 weeks after their initial injections of faricimab.
-
Long-term follow-up of EXG102-031 treatment for wet age-related macular degeneration
This follow-up will monitor people who previously received the EXG102-031 gene therapy for wet AMD to see if the treatment remains safe and continues to work over five years.
-
Low-dose oral doxycycline targeting MMP-9 for persistent wet AMD
This trial tests whether taking low-dose doxycycline daily can help people with wet AMD who still have sub-retinal fluid despite regular anti-VEGF eye injections.
Related topics
Quick answers
How many Wet Age-related Macular Degeneration clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Czechia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.